These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different ways to help people lose ...

Americans largely believe that losing weight can make a big difference both in daily life and in the country as a whole. In ...

Obesity is more than a cosmetic concern. It’s a chronic disease that can be treated with drugs like semaglutide (Wegovy) and ...

Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug ...

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...

In the quest for effective weight loss solutions, AquaSculpt has emerged as a game-changer, captivating the attention of ...

But studies show that even small calorie deficits (of 100-200 calories daily) can lead to long-term, sustainable weight-loss ...

Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

From starting small to practicing mindful eating, these expert-backed tips offer realistic, sustainable ways to reach your ...